LOGIN  |  REGISTER
C4 Therapeutics
Cue Biopharma

Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference

October 29, 2024 | Last Trade: US$10.69 0.05 0.47

PITTSBURGH, Oct. 29, 2024 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the company will participate in two upcoming healthcare conferences.

Details of the presentations can be found below:

UBS Global Healthcare Conference

  • Date: Tuesday, November 12, 2024
  • Time: 8:45 a.m. PT / 11:45 a.m. ET
  • Location: Terranea Resort in Rancho Palos Verdes, California
  • Format: Fireside chat with Viatris executives

Jeffries London Healthcare Conference 

  • Date: Thursday, November 21, 2024
  • Time: 10:30 a.m. GMT / 5:30 a.m. ET
  • Location: Waldorf Hilton Hotel in London, England
  • Format: Fireside chat with Viatris executives

Interested parties can access live webcasts of both events at investor.viatris.com. An archived version also will be available following the live event and can be accessed at the same location for a limited time. 

About Viatris

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X (formerly Twitter).

 
Astria Therapeutics

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page